Program

2018 March Annual Meeting Program

Thursday, March 1, 2018

8:00 a.m. Welcome Remarks
Edouard Trabulsi, MD, President
    
8:10 – 8:25 a.m.
Update on AUA Initiatives

Robert Flanigan, MD, AUA President-Elect

8:25 – 8:30 a.m. Update on AUA Basic Science Course
Jay Raman, MD, Secretary

8:30 – 9:30 a.m.
AUA Course of Choice

 AUA/ASTRO/SUO Guidelines 2017:Localized Prostate Cancer
 Martin Sanda, MD, Emory

9:30 – 10:15 a.m. Evolving Genetic and Genomic
Influences on Prostate Cancer
 Moderator & Review of AUA Guidelines on Localized Prostate Cancer:
 Adam Reese,  MD, Temple University
Genomics: Paul Sieber, MD, Lancaster Urology
 Genetics: Veda Giri, MD, Thomas Jefferson University Hospital

10:15 – 10:45 a.m. Coffee Break with Exhibitors 

10:45 – Noon Moderated Poster Session 1: Bladder & Testis Cancer; Workforce

Moderated Poster Session 2: General Urology; Infertility

Noon – 1 p.m. Lunch in Exhibit Hall

1:15 – 2 p.m. Sequencing of New Agents for CRPC
 Moderator & Review of AUA Guidlines on CRPRC:
 Mark Mann, MD, Thomas Jefferson University
Michael Williams, MD, Eastern Virginia Medical School 

2 – 2:30 p.m.
Coffee Break with Exhibitors


2:30 – 3:15 p.m. Management Dilemmas in Lower GU Tract
 Reconstruction:
Peyronie's Disease and Infected IPP
Moderator: Paul Chung, MD
Susan MacDonald, MD
Jay Simhan, MD

3:15 – 5 p.m. Moderated Poster Session 3: Prostate Cancer

Moderated Poster Session 4: Female Urology; Incontinence; Reconstruction

5 – 5:30 p.m. Newly Released AUA Guidelines Update
Stress Urinary Incontinence
Jay Simhan, MD, Einstein Healthcare Network
Renal Mass and Localized Renal Cancer
Keith Kowalczyk, MD, Georgetown University
Medical Stone Management
Roger Schultz, MD, Williamsburg, VA

5:30 – 7:00 p.m. Welcome Reception in Exhibit Hall

7:00 – 8:00 p.m. Residents Jeopardy Bowl

Friday, September 15, 2017

7 - 8 a.m. Breakfast Symposium
Sponsored by: Augmenix
 SpaceOAR Hydrogel: What Every Urologist Should Know
 Presenter: Michael J. Naslund, MD
Non-CME


8:15 – 9:30 a.m. Resident Prize Essay Podium Session


9:30 – 10:30 a.m. Paul F. Schellhammer Lecture
High Risk Prostate Cancer: Contemporary Treatment Paradigms, Outcomes

 and Future Directions
Daniel Lin, MD, University of Washington, Seattle

10:30 - 11:00 a.m. Coffee Break with Exhibitors

11:00 a.m. – 12:30 p.m. Moderated Poster Session 5: Renal Cancer; Oncology Risk

Moderated Poster Session 6: Pediatrics; Endourology; Practice Patterns

12:45 – 1:45 p.m. Lunch Symposium
Sponsored by: Astellas Pharma US, Inc.
and Pfizer Oncology
Elevate Care in Advanced Prostate Cancer
 Presenter: Paul Sieber, MD
Non-CME

2 – 5 p.m. Free Afternoon - Golf & Tennis Available

6 – 8 p.m. Themed Reception

Saturday, March 3, 2018

6:30 – 8  a.m. Breakfast Symposium
 Sponsored by: Nymox Pharmaceuticals Fexapotide Triflutate:
 Long-Term Safety and Efficacy of First In Class Injectable for BPH
Non-CME


8:15 – 9 a.m. Annual Member Business Meeting

9 – 9:15 a.m. ABU Update
Gerald Jordan, MD

9:15 – 10:30 a.m. Health Policy Panel 
MACRA in 2018 – How to Prepare
Jean Moody-Williams, RN, MPP,
Centers for Medicare & Medicaid Services
Kim Ramsey, Director of Clinical Operations,
Urology of Virginia

10:30 – 10:45 a.m. Coffee Break 

10:45 – 11:45 a.m. Hugh Hampton Young Lecture 
The Changing Face of Urologic Oncologic Surgery
Over 15 Years: The Impact of Robotics
Inderbir Gill, MD, MCh
University of Southern California 

11:45 a.m. – 12:45 p.m. Bladder Cancer –
Diagnosis, Treatment and MIBC Guidelines and
Immunotherapy in NMI and MI Bladder Cancer
Moderator: Piyush Agarwal, MD, National Cancer Institute
Lambros Stamatakis, MD, Washington Hospital Center
Andrea Apolo, MD National Cancer Institute

12:45 – 1:45 p.m. Lunch Symposium
Sponsored by: Pacific Edge Diagnostics
 Use of Urinary Markers in the Management of NMIBC
Non-CME

1:45 – 2:30 p.m. Howard Pollack Pyelogram Lecture
Prostate MRI for the Urologist
Moderator: Gordon Brown, MD
Minhaj Siddiqui, MD, University of Maryland



2:30 – 3:30 p.m. Update on Surgical Management of
Urolithiasis – PCNL Access
Moderator: Brant Fulmer, MD Geisinger Urology
Summary of Endourology Disease
Group Excellence (EDGE)
Consortium Data and Recommendations
Alyssa Park, MD, Geisinger Urology
Antegrade Access for PCNL
Noah Schenkman, MD, University of Virginia
Retrograde Access for PCNL
Joseph Clark, MD, Penn State Hershey 

3:30 – 3:45 p.m. Coffee Break

3:45 – 4:00 p.m. IVUmed Scholar Presentation
Recent Experience in Haiti
Amar Raval, MD, Thomas Jefferson University 

4 – 5 p.m. Young Urologist Committee Sponsored Session
Understanding, Managing and
Preventing Physician Burnout in Urology
Modeator: John Knoedler, MD
Joshua Langtson, MD
Tullika Garg, MD, Geisinger Urology


5 – 6 p.m. Social Hour Reception
        Sponsored by Sentara/University of Virginia

7:00 – 10 p.m. President’s Banquet- 75th Anniversary Celebration

Social Events

Attend these fun networking events included in the price of registration.

Thursday, March 1
Welcome Reception
Mingle with colleagues and visit our exhibitors. Be sure to thank our industry partners for their support.

Friday, March 2
Exhibit Hall Closing Reception & Themed Party
Spend a casual evening with friends and colleagues while sipping a cocktail and enjoying the ocean breeze.

Saturday, March 3
President’s Banquet
Join us for the Section’s 75th Anniversary Celebration!

 

Accreditation Information

Accreditation:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Urological Association Education and Research, Inc. (AUAER) and Mid-Atlantic Section of the AUA. The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation:  The American Urological Association designates this Mid-Atlantic Section Annual Meeting activity for a maximum of 17.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.